Tender Notice Africa Pharmaceuticals

Consulting Services, Implementation of the Afreximbank Project “prep4vac” (Vaccine Manufacturing)

Cancellation Notice KfW

Mar 08, 2024

  • Country Africa, Africa, overall
  • Financing KfW Entwicklungsbank
  • Reference Number BMZ202167161/KfW509642; KfW-Inpro-Nr. 52087; 01/2023
  • Subject Project “prep4vac”

CANCELLATION OF TENDER

 

Requested Services

  • The African Union (AU) aims to vaccinate 60 % of the entire African population. In order to prepare investments along the entire value chain of vaccine manufacturing and the manufacturing of other medical and pharmaceutical products and their respective accessory products, the Afreximbank has received grant financing from KfW. The Consultant is expected to work in close cooperation with Afreximbank and to support the management of the prep4vac project. In this role, the Consultant shall provide operational management and guidance, and ensure the implementation and completion of the prep4vac project tasks. In particular the Consultant shall support Afreximbank with Project Management, Project Implementation Support as well as Stakeholder Communication and Coordination.

     

Publication of Prequalified Applicants


Publication Date of Prequalification Notice on GTAI-Website: 26/04/2023


List of Names of Prequalified Applicants (in alphabetical order):

Name of Applicant 

Name of JV-Partners 

 Name of Sub-Consultants 

management4health GmbH 

Biomedhelix (Pty) Ltd. 

GOPA Worldwide Consultants GmbH 

The university of Rwanda - College of Medicine & Health Sciences EAC Regional Centre of Excellence for Vaccines, Immunization & Health Supply Chain Management 

IDOM CONSULTING, ENGINEERING, AR-CHITECTURE S.A.U. 

Particip GmbH 

Group-IPS and International Engineering and Architecture Manager of Group IPS 


There are no further details available for the message. Please always enter the following ID when making inquiries: AUS20230425998772